Targeted genomic sequence analysis panel of rna of 51 or greater genes associated with blood and lymphatic system disorders
Medicare pricing data for 23 providers across 5 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Targeted genomic sequence analysis panel of rna of 51 or greater genes associated with blood and lymphatic system disorders (HCPCS code 81456) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $2,856, but hospitals typically charge $3,877 — a 1.4x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $2,856, your out-of-pocket cost would be approximately $571.27. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.4x more than what Medicare allows for this procedure. Medicare actually pays $2,856 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Florida | $2,861 | $5,887 | 14 | 223 | +0.2% |
| Maryland | $2,861 | $7,786 | 1 | 14 | +0.2% |
| Minnesota | $2,861 | $3,071 | 3 | 13 | +0.2% |
| Illinois | $2,856 | $3,797 | 1 | 14,721 | +0.0% |
| New Jersey | $2,839 | $9,051 | 2 | 129 | -0.6% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber